Clinical Trial Update: Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ribociclib in combination with an aromatase inhibitor for older adults with estrogen receptor-positive, HER2-negative metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)
• Ribociclib (ribociclib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative | Phase 2 | Status: COMPLETED | Results posted: 2022-05-18